mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.2 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |